Coral Laboratories Limited (BOM:524506)
India · Delayed Price · Currency is INR 498.00
+3.15 (0.64%)
At close: Nov 6, 2026
Coral Laboratories Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 1,779 | 1,324 | 2,506 | 1,327 | 818 | 912 | |
Market Cap Growth | 0.71% | -47.17% | 88.85% | 62.25% | -10.34% | -20.78% |
Enterprise Value | 804 | 309 | 1,593 | 548 | 347 | 518 |
Last Close Price | 498.00 | 369.25 | 696.98 | 368.23 | 226.95 | 253.12 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 9.27 | 8.08 | 10.37 | 8.40 | 12.69 | 10.08 |
PS Ratio | 1.84 | 1.54 | 2.18 | 1.59 | 1.05 | 1.21 |
PB Ratio | 0.85 | 0.63 | 1.25 | 0.75 | 0.53 | 0.58 |
P/TBV Ratio | 0.85 | 0.63 | 1.25 | 0.75 | 0.53 | 0.59 |
P/FCF Ratio | - | - | - | - | 7.63 | 170.36 |
P/OCF Ratio | 11.39 | 8.48 | - | - | 6.46 | 14.99 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 0.83 | 0.36 | 1.39 | 0.66 | 0.44 | 0.69 |
EV/EBITDA Ratio | 4.38 | 1.99 | 5.99 | 3.30 | 8.17 | 6.05 |
EV/EBIT Ratio | 4.97 | 2.30 | 6.48 | 3.75 | 16.73 | 7.86 |
EV/FCF Ratio | - | - | - | - | 3.24 | 96.82 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.02 | 0.02 | 0.02 | - | - | 0.04 |
Debt / EBITDA Ratio | 0.24 | 0.28 | 0.13 | - | - | 0.70 |
Debt / FCF Ratio | - | - | - | - | - | 11.28 |
Net Debt / Equity Ratio | -0.47 | -0.13 | -0.14 | -0.16 | -0.19 | -0.12 |
Net Debt / EBITDA Ratio | -5.32 | -1.69 | -1.03 | -1.68 | -7.07 | -2.13 |
Net Debt / FCF Ratio | - | 3.33 | 6.57 | 4.30 | -2.80 | -34.04 |
Asset Turnover | - | 0.37 | 0.53 | 0.44 | 0.43 | 0.42 |
Inventory Turnover | - | 2.41 | 4.32 | 2.76 | 3.03 | 2.04 |
Quick Ratio | - | 2.20 | 2.59 | 2.25 | 4.51 | 2.44 |
Current Ratio | - | 6.48 | 7.07 | 6.18 | 10.42 | 5.13 |
Return on Equity (ROE) | - | 7.99% | 12.76% | 9.50% | 4.15% | 6.18% |
Return on Assets (ROA) | - | 3.58% | 7.07% | 4.81% | 0.71% | 2.31% |
Return on Invested Capital (ROIC) | 8.01% | 5.35% | 11.31% | 8.11% | 1.24% | 3.88% |
Return on Capital Employed (ROCE) | - | 6.30% | 12.00% | 8.10% | 1.30% | 4.00% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 10.79% | 12.37% | 9.64% | 11.90% | 7.88% | 9.92% |
FCF Yield | -4.45% | -5.98% | -1.66% | -4.87% | 13.11% | 0.59% |
Dividend Yield | 0.40% | 0.54% | 0.21% | 0.54% | - | - |
Payout Ratio | 3.72% | 3.27% | 2.96% | - | - | - |
Total Shareholder Return | 0.38% | 0.54% | 0.21% | 0.54% | - | - |